DD283811A5 - Verfahren zur herstellung von alpha-substituierten 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester - Google Patents

Verfahren zur herstellung von alpha-substituierten 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester Download PDF

Info

Publication number
DD283811A5
DD283811A5 DD89328033A DD32803389A DD283811A5 DD 283811 A5 DD283811 A5 DD 283811A5 DD 89328033 A DD89328033 A DD 89328033A DD 32803389 A DD32803389 A DD 32803389A DD 283811 A5 DD283811 A5 DD 283811A5
Authority
DD
German Democratic Republic
Prior art keywords
methoxy
quinolin
acid
phenyl
esters
Prior art date
Application number
DD89328033A
Other languages
German (de)
English (en)
Inventor
Klaus Mohrs
Siegfried Raddatz
Romanis Fruchtmann
Christian Kohlsdorfer
Reiner Mueller-Peddinghaus
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD283811A5 publication Critical patent/DD283811A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD89328033A 1988-04-29 1989-04-27 Verfahren zur herstellung von alpha-substituierten 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester DD283811A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3814504A DE3814504A1 (de) 1988-04-29 1988-04-29 (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
DD283811A5 true DD283811A5 (de) 1990-10-24

Family

ID=6353182

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89328033A DD283811A5 (de) 1988-04-29 1989-04-27 Verfahren zur herstellung von alpha-substituierten 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester

Country Status (20)

Country Link
US (1) US4929626A (zh)
EP (1) EP0339416B1 (zh)
JP (1) JPH01313466A (zh)
KR (1) KR900016136A (zh)
CN (1) CN1027068C (zh)
AT (1) ATE89819T1 (zh)
AU (1) AU614358B2 (zh)
CA (1) CA1333803C (zh)
DD (1) DD283811A5 (zh)
DE (2) DE3814504A1 (zh)
DK (1) DK168009B1 (zh)
ES (1) ES2054919T3 (zh)
FI (1) FI91855C (zh)
HU (1) HU205079B (zh)
IE (1) IE62888B1 (zh)
IL (1) IL90052A (zh)
NO (1) NO175149C (zh)
NZ (1) NZ228899A (zh)
PT (1) PT90382B (zh)
ZA (1) ZA893171B (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3632329A1 (de) * 1986-09-24 1988-03-31 Bayer Ag Substituierte phenylsulfonamide
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
US5232916A (en) * 1988-06-27 1993-08-03 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
US5102881A (en) * 1988-06-27 1992-04-07 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
US5194438A (en) * 1988-07-15 1993-03-16 Basf Aktiengesellschaft α-arylacrylates substituted by a trifluoromethylpyrimidinyloxy radical, fungicidal compositions and methods
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
US5071988A (en) * 1989-10-27 1991-12-10 American Home Products Corporation Substituted benzoylbenzene-, biphenyl- and 2-oxazole-alkanoic acid derivatives
US5021576A (en) * 1989-10-27 1991-06-04 American Home Products Corporation 2-Anilino phenylacetic acid derivatives
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US5254581A (en) * 1990-06-21 1993-10-19 Imperial Chemical Industries Plc Pyran derivatives and their use as inhibitors of 5-lipoxygenase
US4996214A (en) * 1990-06-28 1991-02-26 Smithkline Beecham Corporation Quinolinyl substituted phenyl/thioalkanoic acid substituted propionic acids and leucotriene antagonist use thereof
US5187180A (en) * 1990-07-26 1993-02-16 Merck Frosst Canada, Inc. (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
US5221678A (en) * 1990-07-26 1993-06-22 Merck Frosst Canada, Inc. (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
US5266568A (en) * 1990-10-12 1993-11-30 Merck Frosst Canada, Inc. Hydroxyalkylquinoline ether acids as leukotriene antagonists
US5856322A (en) * 1990-10-12 1999-01-05 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4139751A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Thiazolyl substituierte chinolylmethoxyphenylessigsaeurederivate
DE4226649A1 (de) * 1992-08-12 1994-02-17 Bayer Ag Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
EP0540165A1 (en) * 1991-10-03 1993-05-05 Zeneca Limited Alkanoic acid derivatives
DE4139750A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenylessigsaeure-acylamide und -harnstoffe
US5270324A (en) * 1992-04-10 1993-12-14 Merck Frosst Canada, Inc. Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
DE4226519A1 (de) * 1992-08-11 1994-02-17 Bayer Ag 3-Substituierte Chinolylmethoxy-phenylessigsäurederivate
ES2061406B1 (es) * 1993-05-07 1995-06-01 Uriach & Cia Sa J Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
EP2086531A4 (en) 2006-11-30 2009-09-30 Amira Pharmaceuticals Inc COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS
EP3102209B1 (en) 2014-02-04 2021-04-07 Bioscience Pharma Partners, LLC Use of flap inhibitors to reduce neuroinflammation mediated injury in the central nervous system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
JPH0729952B2 (ja) * 1984-10-30 1995-04-05 ユ−エスヴイ− フア−マシユ−テイカル コ−ポレ−シヨン 抗炎症及び抗アレルギ−化合物
NZ213986A (en) * 1984-10-30 1989-07-27 Usv Pharma Corp Heterocyclic or aromatic compounds, and pharmaceutical compositions containing such
US4642347A (en) * 1985-05-21 1987-02-10 American Home Products Corporation 3(2-quinolinylalkoxy)phenols
US4661499A (en) * 1985-06-18 1987-04-28 Merck Frosst Canada, Inc. 2-[(substituted)-phenoxymethyl]quinolines

Also Published As

Publication number Publication date
DK208789D0 (da) 1989-04-28
CA1333803C (en) 1995-01-03
IL90052A0 (en) 1989-12-15
CN1045777A (zh) 1990-10-03
FI892016A0 (fi) 1989-04-27
FI91855B (fi) 1994-05-13
US4929626A (en) 1990-05-29
PT90382B (pt) 1994-09-30
NO175149B (no) 1994-05-30
ZA893171B (en) 1989-12-27
ES2054919T3 (es) 1994-08-16
DK208789A (da) 1989-10-30
HU205079B (en) 1992-03-30
IE891402L (en) 1989-10-29
AU3385289A (en) 1989-11-02
NO175149C (no) 1994-09-07
HUT50779A (en) 1990-03-28
PT90382A (pt) 1989-11-10
EP0339416B1 (de) 1993-05-26
NO891523D0 (no) 1989-04-13
EP0339416A1 (de) 1989-11-02
NZ228899A (en) 1991-06-25
AU614358B2 (en) 1991-08-29
IE62888B1 (en) 1995-03-08
JPH01313466A (ja) 1989-12-18
CN1027068C (zh) 1994-12-21
NO891523L (no) 1989-10-30
DE58904459D1 (de) 1993-07-01
FI892016A (fi) 1989-10-30
ATE89819T1 (de) 1993-06-15
DE3814504A1 (de) 1989-11-09
FI91855C (fi) 1994-08-25
IL90052A (en) 1993-07-08
DK168009B1 (da) 1994-01-17
KR900016136A (ko) 1990-11-12

Similar Documents

Publication Publication Date Title
DD283811A5 (de) Verfahren zur herstellung von alpha-substituierten 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester
EP0261539B1 (de) Substituierte Phenylsulfonamide
EP0344519B1 (de) Substituierte 4-(Chinolin-2-yl-methoxy)phenyl-essigsäure-Derivate
DE2658544A1 (de) Carbostyrilderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
EP0224086B1 (de) Substituierte Benzylether
EP0778271A2 (de) Aminoalkyl-substituierte benzo-heterocyclische Verbindungen
EP0399291B1 (de) Substituierte (Chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0414078B1 (de) Disubstituierte (Chinolin-2-yl-methoxy) phenylessigsäure-Derivate
EP0414076B1 (de) Cyclisch substituierte (Chinolin-2-yl-methoxy)phenyl-essigsäure-Derivate
EP0414019B1 (de) Substituierte N-(Chinolin-2-yl-methoxy)benzylsulfonylharnstoffe
EP0716082B1 (de) Bicyclisch substituierte Oxy-phenyl-(phenyl) glycinolamide mit antiatherosklerotischer Wirkung
EP0409027A1 (de) Neue Indolderivate, Verfahren zu deren Herstellung und deren Verwendung in Arzneimitteln
AT368131B (de) Verfahren zur herstellung von neuen 9-aminoalkyl- fluorenen und von deren salzen
CH650783A5 (de) Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
DD145104B3 (de) Verfahren zur herstellung von polyalkoxyphenylpyrrolidone
EP0515940B1 (de) Neue 2-Amino-5-cyano-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0529450B1 (de) Substituierte Mandelsäurederivate, als 5-Lipoxygenasehemmer
EP0582908B1 (de) 2-Substituierte Chinolylmethoxy-phenylessigsäure- und -benzylacyl Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Leukotriensynthese Hemmer
EP0802186A1 (de) Benzyloxy-substituierte Phenylglycinolamide als Arzneimittel
EP0387610A2 (de) Substituierte (Chinolin-2-yl-methoxy)phenyl-N,N'-sulfonyl-harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4139749A1 (de) Chinolylmethoxyphenyl-essigsaeureamide
DE3905908A1 (de) Substituierte chinoline, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
EP0424722B1 (de) Substituierte (Chinolin-2-yl-methoxy)phenyl-thioharnstoffe
DE4226649A1 (de) Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
DD283612A5 (de) Verfahren zur herstellung von substituierten imidazolinonen und imidazolinthionen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee